News Sentiment

CAMP sentiment intelligence

CAMP4 THERAPEUTICS CORPORATION news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Weighted score 59 Balanced news tone 47 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 3.71 Week of 17 Jul 2026
Weighted tone 59/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

75/100 classification confidence.

Company focus 38

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

-14.3% over one week, -10.2% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Positive

We Think Camp4 Therapeutics (NASDAQ:CAMP) Can Afford To Drive Business Growth

Market Reaction

Price moving ahead of tone

67/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 75/100 classification
One-week reaction -14.3% Price reacting lower
Trend fit Trend inactive -10.2% over four weeks
Fair value -12.4% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 21
Neutral 25
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 38
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 10
Market source 8
GlobeNewswire 5
TradingKey 5
simplywall.st 3
Finviz 3
MT Newswires 3
Insider Monkey 2

Event Lens

What the news is about

Classified themes
Market update 20
Earnings 13
Analyst action 9
Balance sheet 3
Capital return 1
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-47 of 47
Stock Titan Direct company coverage

New CAMP4 hire receives 5,000-share stock option grant

CAMP4 Therapeutics (Nasdaq: CAMP) announced it granted a non-qualified stock option to a new employee to purchase 5,000 shares of common stock. This inducement award, granted under Nasdaq Listing Rule 5635(c)(4), has a 10-year term and an exercise price of $4.31, vesting over fou

Tone
Neutral 50/100
Event
Market update
Published
24 May 2026 08:09
Source
Stock Titan